FIORUCCI, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 12.108
EU - Europa 8.996
AS - Asia 3.230
SA - Sud America 48
Continente sconosciuto - Info sul continente non disponibili 15
AF - Africa 11
OC - Oceania 7
Totale 24.415
Nazione #
US - Stati Uniti d'America 11.998
IE - Irlanda 2.041
UA - Ucraina 2.003
SE - Svezia 1.438
SG - Singapore 1.303
IT - Italia 1.161
VN - Vietnam 623
FI - Finlandia 578
HK - Hong Kong 571
DE - Germania 552
RU - Federazione Russa 448
CN - Cina 393
GB - Regno Unito 226
FR - Francia 184
KR - Corea 123
TR - Turchia 119
CH - Svizzera 90
CA - Canada 89
AT - Austria 52
BE - Belgio 41
NL - Olanda 41
PL - Polonia 34
BR - Brasile 33
UZ - Uzbekistan 31
CZ - Repubblica Ceca 30
GR - Grecia 25
LB - Libano 25
RO - Romania 21
MX - Messico 20
EU - Europa 15
ES - Italia 8
JP - Giappone 7
AU - Australia 6
BG - Bulgaria 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
CI - Costa d'Avorio 4
CO - Colombia 4
IN - India 4
PY - Paraguay 4
AM - Armenia 3
EC - Ecuador 3
EG - Egitto 3
KZ - Kazakistan 3
LT - Lituania 3
AL - Albania 2
BD - Bangladesh 2
CL - Cile 2
EE - Estonia 2
HR - Croazia 2
IQ - Iraq 2
IR - Iran 2
RS - Serbia 2
AO - Angola 1
AR - Argentina 1
AZ - Azerbaigian 1
BO - Bolivia 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
GH - Ghana 1
GT - Guatemala 1
HU - Ungheria 1
ID - Indonesia 1
JO - Giordania 1
KG - Kirghizistan 1
LU - Lussemburgo 1
MA - Marocco 1
ME - Montenegro 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TM - Turkmenistan 1
Totale 24.415
Città #
Chandler 2.286
Dublin 2.032
San Mateo 1.227
Singapore 975
Jacksonville 837
Boardman 743
Dong Ket 622
Santa Clara 596
Hong Kong 571
Medford 547
Princeton 542
Altamura 518
Wilmington 497
Lawrence 381
Andover 345
Ann Arbor 341
Des Moines 313
Perugia 237
Ashburn 181
Saint Petersburg 165
Beijing 143
Izmir 116
Helsinki 96
Norwalk 96
Falls Church 95
Ottawa 79
Los Angeles 69
Woodbridge 64
San Paolo di Civitate 57
Shanghai 53
Seoul 48
Brussels 41
Redwood City 35
New York 34
Redmond 33
Dallas 30
Houston 30
Munich 29
Moscow 28
Auburn Hills 25
Den Haag 25
Dearborn 23
Timisoara 18
Vienna 15
Chicago 14
Lausanne 13
Olomouc 12
Rome 12
Tappahannock 12
Lappeenranta 11
Naples 11
Florence 10
Frankfurt Am Main 9
Philadelphia 9
Seattle 9
Amsterdam 8
San Diego 8
Simi Valley 8
London 7
São Paulo 7
Toronto 7
Brugg 6
Guangzhou 6
Kiev 6
Milan 6
Nanjing 6
Tokyo 6
Verona 6
Bologna 5
Cambridge 5
Cuauhtémoc 5
Frankfurt am Main 5
Ludwigshafen 5
Lugano 5
Phoenix 5
Sydney 5
Abidjan 4
Al Ain City 4
Fairfield 4
Fremont 4
Menlo Park 4
Mexico City 4
Napoli 4
Zhengzhou 4
Brno 3
Cairo 3
Catania 3
Edinburgh 3
Fernando De La Mora 3
Giugliano In Campania 3
Hanover 3
Madrid 3
Minerbio 3
Prata Di Pordenone 3
Rovato 3
Shenyang 3
State College 3
Stockholm 3
Taranto 3
Terni 3
Totale 15.567
Nome #
Recombinant galectin-1 prevents experimental colitis in mice via T cell apoptosis. 159
Il reflusso entero-gastrico:quale ruolo nella patogenesi dell' esofagite 135
An NO-derivative of acetaminophen, NCX-701, spares the liver by inhibiting Fas-dependent apoptosis 95
Cancro gastrico localmente avanzato. Dati preliminari di studio di fase II di chemioterapia neoadiuvante, chirurgia radicale e chemioterapia adiuvante ad alte dosi con autotrapianto di cellule staminali da sangue periferico. 90
Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice. 90
Anti-HIV Protease Inhibitors Interact With NSAIDs and Exacerbate Small Intestine Enteropathy Induced by NSAIDs 90
Bombesin-Induced Pancreatic Regeneration in pigs in associated with p46Shc/p52Shc and p42/p44 MAP kinase Phosphorilation 89
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 89
BAR502, a Dual FXR and GPBAR1 Agonist, Reverses Steatosis and Fibrosis in Rodent Model of NASH By Modulating Authophagic Genes 88
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice. 88
An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity 87
Isolated guinea pig gastric chief cells express tumor necrosis factor receptors coupled with the sphingomyelin pathway 85
The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines 85
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 85
A new protective mechanisn in NSAID gastropathy. Evidence that hydrogen sulfide (H2S) modulates gastric mucosal integrity 83
21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties. 83
Aspirin-triggered, cyclooxygenase-2-dependent lipoxin synthesis modulates vascular tone. 82
Anti-very late antigen-1 monoclonal antibody modulates the development of secondary lesion and T-cell response in experimental arthritis 82
Cooperation between Aspirin-triggered lipoxin and nitric oxide (NO) mediates anti-adhesive properties of NCX-4016 (NO-aspirin) on neutrophil-endothelial cell adherence. 81
A magic bullet for mucosal protection...and aspirin is the trigger! 80
Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia. 79
PAR-2 modulates pepsinogen secretion from gastric-isolated chief cells. 79
Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. 79
Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. 79
Prostaglandin-e2 Desensitizes Camp-mediated Pepsinogen Secretion In Chief Cells 78
Nitric oxide regulates immune cell bioenergetic: a mechanism to understand immunomodulatory functions of nitric oxide-releasing anti-inflammatory drugs. 77
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 77
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines 76
BAR 501, a Novel GPBAR1 Ligand, Reverses Intestinal and Liver Inflammatory Models Demonstrating That GPBAR1 Is an Essential Modulator of Innate Immunity in Entero-Hepatic Tissues 76
Essential counter-regulatory role of farnesoid-X-receptor (FXR) for intestinal innate immunity 75
A nitro-arginine derivative of trimebutine (NO2-Arg-Trim) attenuates pain induced by colorectal distension in conscious rats. 75
Bile acid-activated receptors in the treatment of dyslipidemia and related disorders. 75
Diethylstilbestrol-scaffold-based pregnane X receptor modulators 75
3-oxa-lipoxin A4 analog treats colitis induced by Dss by attenuating inflammation and immunity. 73
Effect of bombesin on pancreatic regeneration after subtotal distal pancreasectomy. 73
Antiatherosclerotic effect of farnesoid X receptor. 73
A farnesoid X receptor-small heterodimer partner regulatory cascade modulates tissue metallproteinase inhibitor-1 and matrix metallprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis’ 72
LESIONI FOCALI EPATICHE MALIGNE 72
Nitric oxide inhibits cathepsin B, UPA and plasmin activity via S-nitrosylation in vitro and in vivo. 72
NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. Br J Pharmacol 71
BAR501, A SELECTIVE GPBAR1 AGONIST, PROMOTES ADIPOSE TISSUE BROWNING AND AUTOPHAGY AND IMPROVES LIPID METABOLISM AND STEATO-HEPATITIS IN MICE FEED A HIGH FAT DIET 71
Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophages. 70
Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition 70
Interleukin 18 restores defective Th1 immunity to Candida albicans in caspase 1-deficient mice. 70
PPARs and other nuclear receptors in inflammation. 69
5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. 69
An essential role of Farnesoid X-Receptor in regulating intestinal fibrosis in murine model of chronic colitis 69
Endothelial nitric oxide synthase: the Cinderella of inflammation? 69
Nitric oxide-releasing NSAIDs: a review of their current status. 68
3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.. 68
Indomethacin modulates Mac-1 expression on circulating neutrophils by inducing Ca2+ mobilization and tyrosine kinase activation. 68
Preliminary structure-activity relationship on theonellasterol, a new chemotype of FXR antagonist, from the marine sponge Theonella swinhoei. 68
Pathogenesis of non-steroidal anti-inflammatory drug gastropathy. A Review. 67
Leukotrienes stimulate pepsinogen secretion from guinea pig gastric chief cells by a nitric oxide-dependent pathway 67
Administration of 3 alpha-6 alpha-dihydroxy-7a alpha-fluoro-5 beta-cholanoate (UPF-680) in chronic cholestasis induced by 17 alpha-ethynyl-estradiol (17 alpha EE) in rats. 67
A Comprehensive Analysis of Small Heterodimer Partner (SHP) Target Genes in Hepatic Stellate Cells and the Discovery of a New Class of SHP Agonists That Reduces Liver Fibrosis 67
NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension 66
NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis 66
Anatomia del fegato 66
Activation of FXR Improves Myocardial Fatty Acid Metabolism in a Rodent Model of Liver Steatosis 66
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 66
Barriera mucosa esofagea e meccanismi aggressivi. 65
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. 65
Cyclo-oxygenase isoenzymes. Structural basis for selective inhibition of cyclo-oxygenases by anti-inflammatory agents 64
NO-aspirin: mechanism of action and gastrointestinal safety 64
Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage. 64
Epidermal growth factor modulates pepsinogen secretion in guinea pig gastric chief cells 64
a Farnesoid-X-Receptor (FXR)-Glucocorticoid Receptor (GR) Cascade Regulates Intestinal Innate Immunity in Response to FXR Activation 64
A new nitric oxide steroid derivative (NCX 1015) with enhanced anti-inflammatory properties reduces colonic inflammation in mice. 64
A beta-oxidation-resistant lipoxin A(4) analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction 64
Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors. 64
Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis 64
5-hydroxytryptamine 3-receptor Antagonist Modulates Gallbladder Emptying and Motilin Release Induced By Erythromycin 63
Antinfiammatori non steroidei 63
Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice 63
Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis. 62
The Fanesoid-X-Receptor ligand INT-747 regulates organic transporters alpha and beta (Ost alpha and Ost beta) in liver cells and rodent model of cholestasis 62
Hyperglycemia Inhibits the Erythromycin-induced Gallbladder Emptying In Normal Subjects 62
Atti VII convegno nazionale GISMAD 62
BAR130, A HYODEOXYCHOLIC ACID DERIVATIVE AS THE FIRST EXAMPLE OF DUAL LXR alpha/GPBAR1 AGONIST 62
Analysis of Gastric Cancer Transcriptome Allows the Identification of Histotype Specific Molecular Signatures With Prognostic Potential 62
Helicobacter pylori and non-steroidal anti-inflammatory drugs. 61
TNFalpha processing enzyme inhibitors prevent aspirin-induced TNFalpha release and protect against gastric mucosal injury in rats 61
NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice. 61
NSAID-induced TNF alpha release from macrophages is the key mediator of gastric mucosal injury. 61
Epigenetic Modulation of Adhesion and Proliferation Pathways by Methionine Deficiency Attenuates Potential for Dissemination of Gastric Cancer Cells 61
Nitric oxide inhibits hepatic stellate cell dependent tumor angiogenesis in primary and metastatic liver cancer 60
Nitric oxide modulates pepsinogen secretion induced by calcium-mediated agonist in guinea pig gastric chief cells. 60
Abscess Formation In Hepatocellular-carcinoma - Complications of Percutaneous Ultrasound-guided Ethanol Injection 60
I peptidil leucotrieni regolano la secrezione di pepsinogeno e la mobilitazione del calcio nelle cellule principali isolate 60
Leflunomide protects against dyslipidemia development induced by ritonavir in mice 60
Alkaline esophageal reflux- A misnomer 60
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies 60
Title: nitric oxide and lipoxins: role in inflammation and defence. 59
Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. 59
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatorybowel diseases and arthritis 59
Involvement of Cd44 Variant Isoforms In Hyaluronate Adhesion By Human Activated T-cells 59
3-oxa-lipoxin A4 analog treats colitis induced by Dss by attenuating inflammation and immunity. 59
Cardiac safety and antitumoral activity of a new nitric oxide derivative of pegylated epirubicin in mice. 58
Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner. 58
Totale 7.182
Categoria #
all - tutte 118.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.517


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.178 0 0 0 0 0 53 297 85 417 159 36 131
2020/20214.489 21 387 208 399 1.279 312 215 29 439 166 316 718
2021/20224.328 96 816 68 233 106 173 57 1.466 52 93 389 779
2022/20237.812 605 1.266 68 617 658 992 2 433 2.807 14 243 107
2023/20242.407 206 312 144 50 35 21 464 146 162 94 412 361
2024/20252.401 69 695 224 227 902 284 0 0 0 0 0 0
Totale 25.253